alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>



<ARTICLE> 5
<LEGEND>
                                                                    EXHIBIT 27.1

THIS  SCHEDULE  CONTAINS  SUMMARY  FINANCIAL  INFORMATION   EXTRACTED  FROM  THE
CONSOLIDATED FINANCIAL  STATEMENTS FOR  THE YEAR  ENDED  OCTOBER 2, 1999  AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS

</LEGEND>

<S>                                                           <C>
<PERIOD-TYPE>                                                 YEAR
<FISCAL-YEAR-END>                                             OCT-02-1999
<PERIOD-START>                                                OCT-03-1998
<PERIOD-END>                                                  OCT-02-1999
<CASH>                                                        1,607
<SECURITIES>                                                  0
<RECEIVABLES>                                                 76,225
<ALLOWANCES>                                                  2,572
<INVENTORY>                                                   72,181
<CURRENT-ASSETS>                                              175,073
<PP&E>                                                        57,495
<DEPRECIATION>                                                15,310
<TOTAL-ASSETS>                                                289,322
<CURRENT-LIABILITIES>                                         55,032
<BONDS>                                                       168,703
<PREFERRED-MANDATORY>                                         0
<PREFERRED>                                                   0
<COMMON>                                                      76
<OTHER-SE>                                                    59,747
<TOTAL-LIABILITY-AND-EQUITY>                                  289,322
<SALES>                                                       420,691
<TOTAL-REVENUES>                                              420,691
<CGS>                                                         302,769
<TOTAL-COSTS>                                                 302,769
<OTHER-EXPENSES>                                              0
<LOSS-PROVISION>                                              0
<INTEREST-EXPENSE>                                            18,586
<INCOME-PRETAX>                                               13,853
<INCOME-TAX>                                                  5,602
<INCOME-CONTINUING>                                           8,251
<DISCONTINUED>                                                0
<EXTRAORDINARY>                                               0
<CHANGES>                                                     0
<NET-INCOME>                                                  8,251
<EPS-BASIC>                                                 1.08
<EPS-DILUTED>                                                 1.05


</TABLE>
<TABLE> <S> <C>

<ARTICLE> 9
<MULTIPLIER>  1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-END>                               DEC-31-1999
<CASH>                                           836
<INT-BEARING-DEPOSITS>                            93
<FED-FUNDS-SOLD>                                   0
<TRADING-ASSETS>                                   0
<INVESTMENTS-HELD-FOR-SALE>                        0
<INVESTMENTS-CARRYING>                         2,185
<INVESTMENTS-MARKET>                           2,181
<LOANS>                                      135,346
<ALLOWANCE>                                      100
<TOTAL-ASSETS>                               142,597
<DEPOSITS>                                    83,675
<SHORT-TERM>                                       0
<LIABILITIES-OTHER>                            1,391
<LONG-TERM>                                   36,980
<COMMON>                                          17
<PREFERRED-MANDATORY>                              0
<PREFERRED>                                        0
<OTHER-SE>                                    20,534
<TOTAL-LIABILITIES-AND-EQUITY>               142,597
<INTEREST-LOAN>                                4,795
<INTEREST-INVEST>                                 46
<INTEREST-OTHER>                                  90
<INTEREST-TOTAL>                               4,931
<INTEREST-DEPOSIT>                             1,920
<INTEREST-EXPENSE>                             2,905
<INTEREST-INCOME-NET>                          2,026
<LOAN-LOSSES>                                      0
<SECURITIES-GAINS>                                 0
<EXPENSE-OTHER>                                  843
<INCOME-PRETAX>                                1,206
<INCOME-PRE-EXTRAORDINARY>                       796
<EXTRAORDINARY>                                    0
<CHANGES>                                          0
<NET-INCOME>                                     796
<EPS-BASIC>                                   0.54
<EPS-DILUTED>                                   0.53
<YIELD-ACTUAL>                                  2.93
<LOANS-NON>                                        0
<LOANS-PAST>                                     253
<LOANS-TROUBLED>                                   0
<LOANS-PROBLEM>                                    0
<ALLOWANCE-OPEN>                                 100
<CHARGE-OFFS>                                      0
<RECOVERIES>                                       0
<ALLOWANCE-CLOSE>                                100
<ALLOWANCE-DOMESTIC>                               0
<ALLOWANCE-FOREIGN>                                0
<ALLOWANCE-UNALLOCATED>                          100


</TABLE>
CITY OF ASHEVILLE v. STATE, et al.

No. 244P07.

Supreme Court of North Carolina.

August 23, 2007.

Robert W. Oast, Jr., Daniel G. Clodfelter, T. Randolph Perkins, Mark A. Nebrig, Charlotte, Jeffrey M. Young, Research Triangle Park, for City of Asheville.

Mark A. Davis, W. Dale Talbert, Special Deputy Attorney Generals, Robert B. Long, Jr., Asheville, for State of NC.

W. Scott Jones, Asheville, for County of Buncombe.

Gregory F. Schwitzgebel, III, Raleigh, for NC League of Municipalities.

The following order has been entered on the motion filed on the 29th day of May 2007 by NC League of Municipalities for leave to file Amicus Curiae Brief:

"Motion Dismissed as moot. By order of the Court in conference this the 23rd day of August 2007."
Exhibit 32.1


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2003

In connection with the Annual Report of Market Central, Inc. (the "Company") on
Form 10-KSB for the year ending August 31, 2004 as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), I, Doyal G. Bryant
President and Chief Executive Officer, certify, pursuant to 18 U.S.C. ss.1350,
as adopted pursuant to ss.906 of the Sarbanes-Oxley Act, that:

      (1)   The Report fully complies with the requirements of Section 13(a) or
            15(d) of the Securities Exchange Act of 1934; and

      (2)   The information contained in the Report fairly presents, in all
            material respects, the financial condition and result of operations
            of the Company.


/s/ Doyal G. Bryant
-----------------------------
Doyal G. Bryant
President and Chief Executive Officer
December 13, 2004
* Pursua nt to 5 T H C IR . R. 47.5, the court has determined that

this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4. United States Court of Appeals

Fifth Circuit 

## FILED November 16, 2005 Charles R. Fulbruge III Clerk IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 04-10586

AMERICAN REGISTRY OF RADIOLOGIC TECHNOLOGISTS Plaintiff-Counter Defendant-Appellee,

versus
LUTHER E. MCCLELLLAN Defendant-Counter Claimant-Appellant.

-------------------- Appeal from the United States District Court for the Northern District of Texas

(3:00-CV-0257)

-------------------- Before HIGGINBOTHAM, WIENER, and DENNIS, Circuit Judges.
PER CURIAM: *

AFFIRMED. See 5th Cir. R. 47.6.
# C_2023024EN.01005201.xml

| 23.1.2023 | EN | Official Journal of the European Union | C 24/52 |
| --- | --- | --- | --- |

23.1.2023

EN

Official Journal of the European Union

C 24/52

---

Action brought on 12 November 2022 — Dabrezco Internacional v Commission

(Case T-692/22)

(2023/C 24/70)

Language of the case: Portuguese

Parties

Applicant: Dabrezco Internacional, Lda (Zona Franca da Madeira) (Funchal, Portugal) (represented by: S. Gemas Donário and S. Soares, lawyers)

Defendant: European Commission

Form of order sought

The applicant claims that the General Court should:

| — | annul Commission Decision C(2020) 8550 final of 4 December 2020 on aid scheme SA.21259 (2018/C) (ex 2018/NN) implemented by Portugal for Zona Franca da Madeira (ZFM) — Regime III; |
| --- | --- |

—

annul Commission Decision C(2020) 8550 final of 4 December 2020 on aid scheme SA.21259 (2018/C) (ex 2018/NN) implemented by Portugal for Zona Franca da Madeira (ZFM) — Regime III;

| — | order the Commission to pay the costs. |
| --- | --- |

—

order the Commission to pay the costs.

Pleas in law and main arguments

In support of the action, the applicant relies on five pleas in law that are, essentially, identical or similar to those relied on in Case T-553/22, Thorn Investments v Commission.

---
<TABLE> <S> <C>



<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                             212
<SECURITIES>                                         0
<RECEIVABLES>                                   15,019
<ALLOWANCES>                                     1,035
<INVENTORY>                                     19,355
<CURRENT-ASSETS>                                38,334
<PP&E>                                           9,508
<DEPRECIATION>                                   4,878
<TOTAL-ASSETS>                                  95,988
<CURRENT-LIABILITIES>                            8,155
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            91
<OTHER-SE>                                      79,343
<TOTAL-LIABILITY-AND-EQUITY>                    95,988
<SALES>                                         49,143
<TOTAL-REVENUES>                                49,143
<CGS>                                           25,727
<TOTAL-COSTS>                                   26,452
<OTHER-EXPENSES>                                17,936
<LOSS-PROVISION>                                   135
<INTEREST-EXPENSE>                                   9
<INCOME-PRETAX>                                  5,146
<INCOME-TAX>                                     3,823
<INCOME-CONTINUING>                              1,323
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,323
<EPS-PRIMARY>                                     0.15
<EPS-DILUTED>                                     0.15
        



</TABLE>
II 

110TH CONGRESS 

2D SESSION S. 3601 

To authorize funding for the National Crime Victim Law Institute to provide 

support for victims of crime under Crime Victims Legal Assistance Programs as a part of the Victims of Crime Act of 1984. 

IN THE SENATE OF THE UNITED STATES 

SEPTEMBER 25 (legislative day, SEPTEMBER 17), 2008 

Mr. KYL (for himself and Mr. LEAHY) introduced the following bill; which was 

read twice and referred to the Committee on the Judiciary 

A BILL 

To authorize funding for the National Crime Victim Law 

Institute to provide support for victims of crime under 

Crime Victims Legal Assistance Programs as a part of 

the Victims of Crime Act of 1984. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. REAUTHORIZATION. 

4 Section 103(b) of the Justice for All Act of 2004 

5 (Public Law 108–405; 118 Stat. 2264) is amended in 

6 paragraphs (1) through (5) by striking ‘‘2006, 2007, 


rwilkins on PROD1PC63 with BILLS
2 

•S 3601 IS

1 2008, and 2009’’ each place it appears and inserting 

2 ‘‘2010, 2011, 2012, and 2013’’. 

Æ 


rwilkins on PROD1PC63 with BILLS
EXHIBIT 32.1



CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report of
Chinawe.com Inc. (the “Company”) on Form 10-K for the year ended December 31, 2018 as filed with the Securities and
Exchange Commission on the date hereof (the “Report”), I, Man Keung Alan Wai, Chief Executive Officer of the Company,
certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:



(1)          The
Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2)          The
information contained in the Report fairly presents, in all material respects, the financial condition and result of operations
of the Company.



|/s/ Man Keung Alan Wai  | 
|----------------------- | 
|Chief Executive Officer | 
|March 29, 2019          | 
|                        | 

A signed original of this written statement required by Section
906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the
electronic version of this written statement required by Section 906, has been provided to Chinawe.com Inc. and will be retained
by Chinawe.com Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
|   | · | The      Annual Report of the Company on Form 10-K for the annual period ended      December 31, 2008, as filed with the Securities and Exchange Commission as      of the date hereof (the “Report”), fully complies with the requirements of      Section 13(a) or 15(d) of the Securities Exchange Act of 1934;      and |
|--------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | · | The      information contained in the Report fairly presents, in all material      respects, the financial condition and results of operations of the      Company. |
|--------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date:  | March      17, 2009 | By:    | /s/ Mark J. Gabrielson       |
|--------|---------------------|--------|------------------------------|
|   |                |   | Mark      J. Gabrielson      |
|   |                |   | Chief      Executive Officer |
|   |                |   |                         |
| Date:  | March      17, 2009 | By:    | /s/ Philip L. Rohrer,Jr.     |
|   |                |   | Philip      L. Rohrer, Jr.   |
|   |                |   | Chief      Financial Officer |
STATE v. McHONE.

No. COA07-1097.

Court of Appeals of North Carolina.

Filed June 17, 2008.

Certification Date July 7, 2008.

Appeal from Stokes (05CRS52910).

Case reported without published opinion. Affirmed.
STATE v. Iziah BARDEN.

No. 96A01-2.

Supreme Court of North Carolina.

September 18, 2007.

Ann B. Petersen, Chapel Hill, for Isiah Barden.

G. Dewey Hudson, District Attorney, for State.

The following order has been entered on the motion filed on the 17th day of September 2007 by Attorney General for Extension of Time to File Brief:

> "Motion Allowed. Plaintiff (State of NC) shall have up to and including the 22nd day of October 2007 to file and serve his/her brief with this Court. By order of the Court in conference this the 18th day of September 2007."
CAMERON v. MERISEL PROPERTIES, et al.

No. 594P07.

Supreme Court of North Carolina.

March 6, 2008.

Jaye E. Bingham, Raleigh, for Merisel Properties.

Steven B. Epstein, John D. Burns, Raleigh, for Cameron.

Prior report: ___ N.CApp. ___, 652 S.E.2d 660.

The following order has been entered on the motion filed on the 22nd day of January 2008 by Defendant to Withdraw Petition for Discretionary Review:

"Motion Allowed by order of the Court in conference this the 6th day of March 2008."
STATE v. DOOLITTLE.

No. COA07-952.

Court of Appeals of North Carolina.

Filed April 15, 2008.

Certification Date May 5, 2008.

Appeal from Rowan (06CRS52024).

Cases reported without published opinion. No error.
[Federal Register Volume 70, Number 172 (Wednesday, September 7, 2005)]
[Rules and Regulations]
[Page 53069]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-17645]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 866

[Docket No. 2003D-0221]


Medical Devices; Immunology and Microbiology Devices; 
Classification of the Endotoxin Assay; Technical Amendment

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule; technical amendment.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) published a final rule 
in the Federal Register of October 31, 2003 (68 FR 62007). The final 
rule classified the endotoxin assay into class II (special controls). 
The agency classified the device into class II (special controls) in 
order to provide reasonable assurance of safety and effectiveness of 
the device. FDA is amending the agency's regulations to redesignate the 
section number listed in the Code of Federal Regulations (CFR) from 
Sec.  866.3610 to Sec.  866.3210.

DATES: This rule is effective September 7, 2005.

FOR FURTHER INFORMATION CONTACT: Freddie M. Poole, Center for Devices 
and Radiological Health (HFZ-440), Food and Drug Administration, 2098 
Gaither Rd., Rockville, MD 20850, 240-276-0496 ext. 1111.

SUPPLEMENTARY INFORMATION: FDA has found that the endotoxin assay 
regulation does not reflect the correct section number listed in the 
CFR. Accordingly, FDA is amending the regulation in Sec.  866.3610 (21 
CFR 866.3610) to correct the error by redesignating the section number 
from Sec.  866.3610 to 866.3210.

List of Subjects in 21 CFR Part 866

    Biologics, Laboratories, Medical devices.

0
Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
authority delegated to the Commissioner of Food and Drugs, 21 CFR part 
866 is amended as follows:

PART 866--IMMUNOLOGY AND MICROBIOLOGY DEVICES

0
1. The authority citation for 21 CFR part 866 continues to read as 
follows:

    Authority: 21 U.S.C. 351, 360, 360c, 360e, 360j, 371.


Sec.  866.3610  [Redesignated as Sec.  866.3210 ]

0
2. Section 866.3610 is redesignated as Sec.  866.3210.

    Dated: August 26, 2005.
Linda S. Kahan,
Deputy Director, Center for Devices and Radiological Health.
[FR Doc. 05-17645 Filed 9-6-05; 8:45 am]
BILLING CODE 4160-01-S
<PAGE>

Exhibit 23.1

                       Consent of Independent Accountants

The Board of Directors
Verticalnet, Inc.:

We consent to the incorporation by reference in the Registration Statements on
Form S-8 (No. 333-72143, No. 333-89305 and No. 333-76326), in the Registration
Statements Form S-3 (No. 333-30254, No. 333-30408, No. 333-34860 and No.
333-76334) on and in the Registration Statement on Form S-4 (No. 333-38170) of
Verticalnet, Inc. of our report dated January 31, 2003, except as to Note 20,
which is as of February 6, 2003, with respect to the consolidated balance sheets
of Verticalnet, Inc. and subsidiaries as of December 31, 2002 and 2001, and the
related consolidated statements of operations, cash flows, shareholders' equity
(deficit) and other comprehensive loss for each of the years in the three-year
period ended December 31, 2002, which report appears in the December 31, 2002
annual report on Form 10-K of Verticalnet, Inc.

Our report refers to the adoption of Statement of Financial Accounting Standards
No. 142, Goodwill and Other Intangible Assets, as of January 1, 2002.

                                    KPMG LLP


Philadelphia, Pennsylvania
March 28, 2003
**EXHIBIT 23.1**
**Consent of Independent Auditors**
We consent to the incorporation by reference in the Registration Statements(Form S-8 Nos. 333-44562, 333-80931 and 333-53083) pertaining to (i) the1997Equity Incentive Plan, (ii) the Employee Stock Purchase Plan, and (iii) the 1997 Non-EmployeeDirectors’ Stock Option Plan, and in the Registration Statement (Form S-3 No.333-60135) and related Prospectus, of our report dated February 8, 2002, withrespect to the consolidated financial statements of Gene Logic Inc. includedin the Annual Report (Form 10-K) for the year ended December 31, 2001.
/S/ ERNST & YOUNG LLP
Baltimore, Maryland